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Abstract The ﬁrst scientiﬁc meeting of the newly
established European SYSGENET network took place at
the Helmholtz Centre for Infection Research (HZI) in
Braunschweig, April 7-9, 2010. About 50 researchers
working in the ﬁeld of systems genetics using mouse
genetic reference populations (GRP) participated in the
meeting and exchanged their results, phenotyping approa-
ches, and data analysis tools for studying systems genetics.
In addition, the future of GRP resources and phenotyping
in Europe was discussed.
The SYSGENET network
SYSGENET represents a network of scientists in Europe
who use mouse genetic reference populations (GRP) to
identify complex genetic factors that inﬂuence phenotypic
traits. Studies with GRPs are expected to contribute to the
discovery of principal biological processes and gene net-
works that are involved in disease phenotypes. The ﬁndings
will be translated to human diseases and represent the basis
for understanding disease etiology and developing new
treatment strategies. These gene networks can be extended
to other species as well.
The researchers in SYSGENET are using various GRPs
as model systems to investigate the biological mechanisms
and gene regulatory networks involved in disease pheno-
types. This approach has been described in many reviews
and reports (Bao et al. 2006; Boon et al. 2009; Bystrykh
et al. 2005; Chesler et al. 2005; Churchill et al. 2004;d e
Haan and Williams 2005; Dejager et al. 2009; Flint and
Mott 2008; Gatti et al. 2007; Hovatta and Barlow 2008;
Jansen and Nap 2001; Johannes et al. 2008; Li et al. 2005;
Michaelson et al. 2009; Morahan et al. 2008b; Peirce et al.
2004; Peters et al. 2007; Roberts et al. 2007). The
SYSGENET network partners are studying phenotypes
relevant to infectious diseases, inﬂammatory disorders,
metabolic diseases, cancer, neurological and psychiatric
disorders, and infertility. The GRPs presently exploited by
the network laboratories include inbred strains, consomic
strains, recombinant inbred strains, congenic strains,
interspeciﬁc recombinant congenic strains, outbred popu-
lations, and the upcoming large recombinant inbred strain
collection known as the Collaborative Cross.
SYSGENET integrates the different national, European,
and worldwide research programs in the ﬁeld of complex
genetics, systems biology, and the development of
sophisticated experimental model systems. SYSGENET
also reaches out to systems genetics programs in the United
States and Australia.
The speciﬁc objectives of SYSGENET are
• to create a European network for systems genetics for
complex genetic trait studies in mouse models by
combining expertise and methods, exchanging results,
and connecting the different ongoing national programs
• to link to research groups studying human complex
genetic diseases
• to prepare concepts for a EU mouse resource infra-
structure for GRPs
• to interact with worldwide systems genetics programs
• to prepare calls for research programs in the ﬁeld of
systems genetics in Europe
Participants of the SYSGENET meeting are given in the appendix.
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Infectious diseases
Infectious diseases continue to represent a threat to human
health. Due to global warming and travel, newly emerging
diseases are spreading at an unprecedented rate around the
world. Examples are the dissemination of antibiotics-
resistant mycobacteria, the new swine inﬂuenza virus
variant, SARS, and West Nile virus (WNV). Several
research groups are using mouse GRPs to identify complex
genetic inﬂuences on the host susceptibility to infections.
GRPs have been and will continue to be an important basis
for understanding infectious diseases in humans. A very
good example for translational research was presented by
Pascal Rihet, who identiﬁed genomic susceptibility regions
to malaria in human populations in Africa (Delahaye et al.
2007) and then continued to compare these results with
studies in mouse GRPs. In this way, a region on human
chromosome 5 and its homologous regions on mouse
chromosomes 11 and 18 were identiﬁed. Subsequent
expression studies in mice will now help to determine
the molecular networks and genes involved. Paul
Denny described the mapping of genetic susceptibility
to Streptococcus pneumonia infections in mouse inbred
strains to chromosomes 7 (Denny et al. 2003) and 4
(unpublished). Infection susceptibility to inﬂuenza was
described by Klaus Schughart, who also pointed out that
high susceptibility includes a hyperreactive immune
response in the host (Srivastava et al. 2009). Xavier
Montagutelli generated a unique resource of Mus spr-
etus 9 C57BL/6 J interspeciﬁc recombinant congenic
strains that carry different genomic fragments of Mus
spretus on a C57BL/6 J background (Burgio et al. 2007).
This GRP was used to identify resistance and susceptibility
regions to various pathogens, including Rift Valley fever,
West Nile virus, Yersinia pestis, and inﬂuenza. The ﬁrst
lines of the Collaborative Cross strains have been screened
by Fuad Iraqi for a number of susceptibility loci to various
pathogens (unpublished). It was remarkable to see that
several quantitative trait loci (QTL) showed high signiﬁ-
cance and that the genomic intervals for several loci were
very narrow, which should make it possible to identify
quickly the underlying quantitative trait genes.
Metabolic diseases
Metabolic diseases in humans are dramatically on the rise;
obesity and related diseases in particular represent a serious
challenge to future health systems. Several groups
addressed the complex genetics of metabolic functions and
disorders using different mouse GRPs. Gudrun Brockmann
reported on the mapping of QTLs for obesity in a speciﬁc
mouse strain isolated in Berlin and the BXD congenic
strain set (Neuschl et al. 2010). The future goal is to relate
these QTLs to genetic polymorphisms that inﬂuence the
immune system. Joan Campbell-Tofte presented the use of
herbal extracts for the treatment of type 2 diabetes in
humans. She nicely illustrated the use of mouse models:
from human to mouse to humans and back to the mouse.
Pe ´ne ´lope Andreux reported on the setting up of a mouse
clinic in Lausanne for a systematic analysis of mouse GRPs
for a large number of metabolic phenotypes, including
mitochondrial functions (Koutnikova et al. 2009). Juan
M. Falcon-Perez described the genomic, proteomic, and
metabolic phenotyping capabilities of their technological
platform and introduced extracellular microvesicles and
metabolomic proﬁles as two new biological sources for
identifying biomarkers for the detection and monitoring of
hepatic diseases (Hackenberg et al. 2009). Abnormalities
and diseases of the liver are also the subject of studies
presented by Karl Kashofer (Kashofer et al. 2009). Several
loci for (nonalcoholic) steatohepatitis have been mapped in
chromosome substitution strains, and a more detailed
mapping in subcongenic strains is ongoing.
Behavior
Althoughratsingeneralwerethespeciesofchoiceforuseby
experimental psychologists to study behavior, mice have
been the preferred animal for behavior geneticists since at
least the 1940 s. In addition, the adaptation of behavioral
assays and the development ofnew methods have conﬁrmed
themouseasoneofthemostpreferredexperimentalsystems
to learn more about the genetic underpinnings of behavior
and associated phenotypes. Martien Kas described the cur-
rently underlying scientiﬁc rationale. Precise measurement
ofawell-described behavioraltraitacross aGRPwillleadto
the identiﬁcation of associated genes and genomic regions.
In the next step these genes can be used to ﬁnd homologous
genes and pathways that contribute to the development of
neuropsychiatric disorders in humans. The translational
value of this interspecies genetic approach was nicely
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123exempliﬁed in a study in which a QTL for avoidance
behavior in mice was related to bipolar disorders in humans
(deMooij-vanMalsenetal.2009).Inasimilarapproach,Iris
Hovatta used a cross-species neurogenomics comparison to
correlate brain region-speciﬁc gene expression patterns and
anxiety-like behavior in mouse GRPs to polymorphisms in
the Finnish population for anxiety disorders (Hovatta et al.
2005). The mouse genes allowed identiﬁcation of potential
candidate genes in humans who predispose to anxiety dis-
orders. Paul Franken presented studies on the identiﬁcation
of genetic traits that inﬂuence homeostatic and circadian
aspects of sleep, and the electroencephalogram in the BXD
GRP and in inter- and backcross panels of mice (Shaw and
Franken 2003). Several genes that play a decisive role were
identiﬁed, and further phenotyping of the extended BXD
GRP is planned. Eero Vasar and Sulev Ko ˜ks described the
role of the Wfs1 gene in knockoutmice foranxiety behavior,
an altered response to morphine and the release of striatal
dopamine (Koks et al. 2009; Luuk et al. 2009). Ewelina
Knapska reported the use of a highly sophisticated cage
system, IntelliCage, to automatically record a number of
different complex behavioral traits in mice (Jaholkowski
et al. 2009). Mice can be housed in social groups but nev-
ertheless tested individually. Ryszard Przewlocki reported
on a systematic study on various inbred mouse strains to
identify genetic determinants of alcohol and drug addiction
(Piechota et al. 2010). Combining these studies with com-
prehensive gene expression analyses revealed that gluco-
corticoid receptor-activated gene expression pathways play
an important role. Wim Crusio studied behavioral traits in
learning and related them to brain anatomy (Crusio and
Schwegler 2005). Thereby, the extent of neuron projections
in the hippocampus could be correlated to more efﬁcient
learning capabilities and these two phenotypes are very
stronglycorrelatedgenetically.GuusSmitgaveanoverview
on a collaborative effort in the Netherlands in which several
research groups have determined various behavioral phe-
notypic traits and QTLs in a commonly used BXD popula-
tion (Loos et al. 2009). Also, they established a mouse
facility in which they are using automated screening cages
with sophisticated video recording and analysis.
Cancer and liver cirrhosis
Cancer is still one of the most frequent causes of death in
Western countries, and understanding its molecular causes
as well as establishing appropriate animal model systems
for the development of new treatment strategies is very
important. Fragiskos Kolisis reported on the setting up of
an infrastructure for a systems biology approach to carci-
nogenesis and aging (Chatziioannou et al. 2009). Under-
standing proteasome function and dysfunction as well as
studying the alterations of the genome and proteome that
account for different cancer phenotypes in a mouse skin
carcinogenesis model are among the research goals. Javier
Santos used GRPs to identify genetic traits for the sus-
ceptibility to radiation-induced thymic lymphomas in
interspeciﬁc recombinant congenic and consomic mouse
strains (Santos et al. 2009). Frank Lammert developed
assay systems to determine genetic causes of liver ﬁbrosis
and inﬂammatory liver carcinogens in the BXD mouse
recombinant congenic GRP (Weber et al. 2008).
Other
Leonard Schalkwyk studied allele-speciﬁc methylation in
humans (Schalkwyk et al. 2010). He estimated that
potentially more than 35,000 sites in the genome exhibit
allele-speciﬁc modiﬁcations, and of these 10% are not in
cis, a number that largely exceeds the number of known
imprinted loci. These ﬁndings suggest that individual
genetic heterogeneity may be much larger than estimated
thus far and may contribute to individual phenotypic dif-
ferences. Jiri Forejt used inter-subspeciﬁc consomic strains
(Gregorova et al. 2008) to investigate male sterility and its
consequences for interspecies hybrid sterility (Mihola et al.
2009). Furthermore, in the livers of inter-subspeciﬁc hybrid
strains he discovered new patterns of gene expression that
were absent from both parental strains.
Bioinformatic aspects of systems genetics
The capture, storage, handling, and analysis of large data
sets will present a speciﬁc challenge for future systems
genetics projects. Ritsert Jansen and Pjotr Prins presented
their approaches to integrate data from various phenotypic
studies, encompassing gene expression, metabolome, and
classical traits, and to develop new tools for advanced and
improved mapping of QTLs (Jansen et al. 2009; Li et al.
2008; Swertz and Jansen 2007). These tools will be pro-
vided to the scientiﬁc community. Andreas Beyer gave a
report on how to integrate data obtained at the post-tran-
scriptional level with RNA expression data. Several loci
that inﬂuence the post-transcriptional regulation of gene
products could be identiﬁed in yeast. Steffen Mo ¨ller
presented his suite for the analysis of expression QTL
(http://eqtl.berlios.de), which is being applied to the anal-
ysis of experimental autoimmune encephalomyelitis in
mouse and rat. Anastasios Bezerianos presented a platform
and developments for the identiﬁcation of gene regulatory
networks integrating protein-protein interactions and
microarray data (Bezerianos and Maraziotis 2008). They
started with yeast data and will soon expand to mouse,
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Morris Swertz presented XGAP, a software platform
developed for data management and integration of large
data sets from phenotyping and genotyping studies (Swertz
et al. 2010). Grant Morahan described the development of
an extended tool for WebQTL that allows a genome-centric
analysis of QTL interactions (unpublished).
Current status of the Collaborative Cross
The Collaborative Cross (CC) is currently being generated
as a community resource for more sensitive and reﬁned
mapping of QTLs. The goal is to breed a large population
of recombinant inbred strains starting from eight founder
strains. The eight founder strains were selected to capture a
large portion of the genetic variation in the mouse genome.
In fact, the genetic variation represented in the CC will be
twice the genetic variation present in the human population
(reviewed in Valdar et al. 2006). The three sites where the
resource is being generated reported the present status of
their breeding colonies; the ﬁnal goal is to generate a total
of 700 lines (Chesler et al. 2008; Iraqi et al. 2008; Morahan
et al. 2008a). Grant Morahan gave an update on the
‘‘Southern Cross’’ being established in Perth, Australia. An
inbreeding depression was observed at generations 7-9. At
present, about 200 strains have been bred beyond genera-
tion 10. The ﬁrst 40 strains are expected to be inbred by the
end of the year. David Threadgill reported the status of the
breeding colony at the University of North Carolina,
Chapel Hill, NC, USA. About 300 lines are currently
breeding at UNC. The ﬁrst 50 recombinant inbred lines will
be available by the end of this year and 200 lines by the end
of 2011. To speed up the inbreeding process, marker-
assisted breeding will be used to create homozygous lines
beyond generation 12. Genome analysis demonstrated that
all parental genomes are well represented in the advanced
generations. The ﬁrst phenotyping analysis showed a large
variation in body weight, exercise propensity, and sus-
ceptibility to pathogens. Richard Mott described the gen-
ome structure of a smaller CC colony, funded by the
Wellcome Trust, which was developed by Fuad Iraqi and is
presently housed in Tel Aviv, Israel. A ﬁrst phenotyping
analysis for the QTLs that affect recombination frequencies
was performed. A full-genome sequencing project to
complete the parental strains with high coverage is
underway at the Sanger Institute.
Conclusion
The two-day meeting in Braunschweig has clearly dem-
onstrated the great value of mouse GRPs in identifying
genetic determinants of complex genetic traits for various
phenotypic traits related to diseases in humans. The part-
ners of the network collectively have great expertise in
disease phenotyping and analysis of genetic reference
populations. Several examples that illustrated the transla-
tion of the knowledge gained in the mouse experimental
systems to humans were presented. Links to clinical
researchers already exist at several places but will have to
be further expanded in the future. Furthermore, mouse
GRPs can be ideally combined with mouse mutant lines
carrying a gene-knockout mutation to determine the effect
of a strong genetic defect in combination with modiﬁer
genes. It also became clear that a strong and sustained
ﬁnancial investment in mouse breeding and phenotyping
facilities as well as in bioinformatic infrastructure is
urgently needed to further advance a systems genetics
approach in Europe.
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www.helmholtz-hzi.de/sysgenet and participants of the
meeting: Klaus Schughart, Helmholtz Center for Infection
Research, Germany; Danny Arends, University of Gron-
ingen, Netherlands; Pe ´ne ´lope Andreux, Ecole Polytech-
nique Fe ´de ´rale de Lausanne, Switzerland; Rudi Balling,
University of Luxembourg, Luxembourg; Andreas Beyer,
TU Dresden, Germany; Anastasios Bezerianos, Biosignal
Processing Lab, Department of Medical Physics, Greece;
Gudrun A. Brockmann, Humboldt University Berlin,
Germany; Wim E. Crusio, University of Bordeaux and
CNRS, France; Joan Campbell-Tofte, University of
Copenhagen, Denmark; Paul Denny, MRC Mammalian
Genetics Unit, UK; Juan M Falcon-Perez, CIC bioGUNE,
CIBERehd, Spain; Jiri Forejt, Institute of Molecular
Genetics, Academy of Sciences, Czech Republic; Paul
Franken, Center for Integrative Genomics, University of
Lausanne, Switzerland; Iiris Hovatta, University of Hel-
sinki, Finland; Fuad Iraqi, Sackler Faculty of Medicine Tel-
Aviv University, Israel; Ritsert C Jansen, University of
Groningen, Netherlands; Leszek Kaczmarek, Polish Acad-
emy of Sciences, Nencki Institute of Experimental Biology,
Poland; Martien J. Kas, Department of Neuroscience
and Pharmacology, University Medical Centre Utrecht,
Netherlands; Karl Kashofer, Medical University of Graz,
Austria; Ewelina Knapska, Nencki Institute, Poland;
Fragiskos Kolisis, Institute of Biological Research and
Biotechnology, National Hellenic Research Foundation,
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Institut Pasteur, France; Grant Morahan, The Western
Australian Institute for Medical Research, Australia; Rich-
ard Mott, Wellcome Trust Centre for Human Genetics,
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Infection Research, Germany; Pjotr Prins, Wageningen
University, Netherlands; Ryszard Przewlocki, Institute of
Pharmacology, Poland; Annamari Ranki, University of
Helsinki, Finland; Javier Santos, Centro de Biologı ´a
Molecular Severo Ochoa-Universidad Auto ´noma de
Madrid, Spain; Pascal Rihet, Aix-Marseille University,
France; Leonard Schalkwyk, King’s College London, UK;
August B Smit, Center for Neurogenomics and Cognitive
Research, Netherlands; Morris Swertz, EBI, UK; David
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